Global X Marijuana Life Sciences Index ETFTSX:HMMJView on Over The Counter Market
- LAST PRICE10.38
- TODAY'S CHANGE (%)0.00 (0.00%)
- Bid / Lots10.26/ 1
- Ask / Lots10.50/ 2
- Open / Previous Close--- / 10.38
- Day Range---
- 52 Week Range
- Volume---
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HMMJ |
|---|---|---|
| 09:32 ET | 400 | 10.1 |
| 09:33 ET | 300 | 10.22 |
| 09:44 ET | 300 | 10.25 |
| 09:50 ET | 500 | 10.21 |
| 10:00 ET | 100 | 10.2 |
| 10:08 ET | 100 | 10.26 |
| 10:24 ET | 600 | 10.3 |
| 10:45 ET | 100 | 10.35 |
| 10:58 ET | 200 | 10.4 |
| 11:21 ET | 1100 | 10.46 |
| 11:34 ET | 100 | 10.43 |
| 12:44 ET | 700 | 10.38 |
| 12:57 ET | 200 | 10.36 |
| 01:04 ET | 400 | 10.37 |
| 01:13 ET | 400 | 10.37 |
| 01:24 ET | 100 | 10.37 |
| 01:31 ET | 200 | 10.39 |
| 02:07 ET | 200 | 10.42 |
| 02:14 ET | 500 | 10.46 |
| 02:41 ET | 300 | 10.44 |
| 02:43 ET | 200 | 10.44 |
| 03:14 ET | 4000 | 10.41 |
| 03:53 ET | 2900 | 10.37 |
| 03:57 ET | 400 | 10.36 |
| 04:00 ET | 400 | 10.38 |
| US Equity | 64.7% |
|---|---|
| CDN Equity | 33.8% |
| Cash | 1.5% |
| Fixed Income | 0 |
| Int'l Equity | 0 |
| Other | 0 |
| Healthcare | 47.7% |
|---|---|
| Real Estate | 20.2% |
| Basic Mat. | 11.3% |
| Industrials | 9.1% |
| Consumer Defensive | 8.6% |
| Consumer Cyclical | 1.3% |
| Technology | 0.3% |
| Communication Services | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Utilities | 0 |
| United States | 65.7% |
|---|---|
| Canada | 34.3% |
| Latin America | 0 |
| Africa | 0 |
| Europe | 0 |
| Asia/Oceania | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Innovative Industrial Properties Inc | Long | 18.4% | -1.31% | $14.1M |
Jazz Pharmaceuticals PLC | Long | 12.8% | -1.31% | $9.8M |
The Scotts Miracle Gro Co Class A | Long | 11.3% | -1.31% | $8.7M |
Tilray Brands Inc | Long | 9.6% | -1.31% | $7.4M |
Chart Industries Inc | Long | 9.1% | -1.31% | $7.0M |
Cronos Group Inc | Long | 8.4% | -1.31% | $6.4M |
SNDL Inc Ordinary Shares | Long | 5.5% | -8.47% | $4.2M |
Corbus Pharmaceuticals Holdings Inc | Long | 4.7% | -1.31% | $3.6M |
Canopy Growth Corp | Long | 3.8% | -1.31% | $2.9M |
Skye Bioscience Inc Ordinary Shares | Long | 3.1% | -1.31% | $2.4M |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | Global X Investments Canada Inc. |
Inception | April 4, 2017 |
HMMJ seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry. To achieve HMMJ’s investment objectives, HMMJ invests and holds the equity securities of the Constituent Issuers in substantially the same proportion as its Underlying Index.
| Total Net Assets | $76.6M |
|---|---|
| Shares Out. | 7.4M |
| Net Asset Value (NAV) | $10.09 |
| Prem/Discount to NAV | -0.25% |
| P/E Ratio | --- |
| Dividend Yield | 2.59% |
| Dividend per Share | 0.27 CAD |
| Ex-Dividend Date | 09/27/2024 |
| Dividend Payment Date | 10/7/2024 |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Small Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.75% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.95% |